FdaApplication
ANDA 203825
Identifiers
- fda_app_no: ANDA203825
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT III |
| application_type | ANDA |
| approval_date | 2020-11-03 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 10MG BASE | TABLET;ORAL |
| NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 2.5MG BASE | TABLET;ORAL |
| NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 20MG BASE | TABLET;ORAL |
| NEBIVOLOL HYDROCHLORIDE | NEBIVOLOL HYDROCHLORIDE | EQ 5MG BASE | TABLET;ORAL |
4 products